- Home
- WTFCM vs SRPT Comparison
WTFCM vs SRPT Comparison
Compare WTFCM & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTFCM
- SRPT
- Stock Information
- Founded
- WTFCM N/A
- SRPT 1980
- Country
- WTFCM United States
- SRPT United States
- Employees
- WTFCM 5903
- SRPT N/A
- Industry
- WTFCM Major Banks
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- WTFCM Finance
- SRPT Health Care
- Exchange
- WTFCM Nasdaq
- SRPT Nasdaq
- Market Cap
- WTFCM N/A
- SRPT N/A
- IPO Year
- WTFCM N/A
- SRPT 1997
- Fundamental
- Price
- WTFCM $24.96
- SRPT $18.24
- Analyst Decision
- WTFCM
- SRPT Buy
- Analyst Count
- WTFCM 0
- SRPT 25
- Target Price
- WTFCM N/A
- SRPT $64.00
- AVG Volume (30 Days)
- WTFCM N/A
- SRPT 7.9M
- Earning Date
- WTFCM N/A
- SRPT 08-06-2025
- Dividend Yield
- WTFCM N/A
- SRPT N/A
- EPS Growth
- WTFCM N/A
- SRPT N/A
- EPS
- WTFCM N/A
- SRPT N/A
- Revenue
- WTFCM N/A
- SRPT $2,233,371,000.00
- Revenue This Year
- WTFCM N/A
- SRPT $26.87
- Revenue Next Year
- WTFCM N/A
- SRPT $3.15
- P/E Ratio
- WTFCM N/A
- SRPT N/A
- Revenue Growth
- WTFCM N/A
- SRPT 59.15
- 52 Week Low
- WTFCM N/A
- SRPT $16.88
- 52 Week High
- WTFCM N/A
- SRPT $155.95
- Technical
- Relative Strength Index (RSI)
- WTFCM 28.03
- SRPT 23.09
- Support Level
- WTFCM $24.94
- SRPT $16.88
- Resistance Level
- WTFCM $25.36
- SRPT $18.62
- Average True Range (ATR)
- WTFCM 0.02
- SRPT 1.40
- MACD
- WTFCM -0.05
- SRPT 0.09
- Stochastic Oscillator
- WTFCM 5.90
- SRPT 6.41
About WTFCM Wintrust Financial Corporation Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series D
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.